| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000024752 |
| Receipt No. | R000028446 |
| Official scientific title of the study | Effect of repetitive transcranial magnetic stimulation (rTMS) on brain morphology and function in refractory mental disorders |
| Date of disclosure of the study information | 2016/12/01 |
| Last modified on | 2017/05/09 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Effect of repetitive transcranial magnetic stimulation (rTMS) on brain morphology and function in refractory mental disorders | |
| Title of the study (Brief title) | Effect of repetitive transcranial magnetic stimulation (rTMS) | |
| Region |
|
|
| Condition | ||
| Condition | patients with depressive state who meet criteria for mood disorders or schizophrenia | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate the effectiveness of rTMS (real or sham stimulation) on brain morphology and function in patients with depressive state who meet criteria of mood disorders or schizophrenia. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Hamilton Rating Scale for Depression |
| Key secondary outcomes | Beck Depression Inventory
Brief Assesment of Cognition in Schizophrenia-Japanese version(BACS-J) brain MRI brain SPECT |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Single blind -participants are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | 1)real rTMS (20Hz), 2000 pulses per session
2)five treatment sessions per week during a period of four to six weeks |
|
| Interventions/Control_2 | 1)sham rTMS
2)five treatment sessions per week during a period of four to six weeks |
|
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1)patient with depressive state, who meets ICD-10 criteria for mood disorders or schizophrenia
2)non responder to medication for over half a year 3)20 years of age or over 4)gave written informed consent |
|||
| Key exclusion criteria | 1)past history of seizure
2)intracerebral metal 3)dependence on alcohol 4)serious cardiac disorder 5)cochlea implant 6)artificial cardiac pacemaker 7)infusion pump 8)any other patients who are regarded as unsuitable for this study by the investigator |
|||
| Target sample size | 30 | |||
| Research contact person | |
| Name of lead principal investigator | Yuko Higuchi |
| Organization | University of Toyama |
| Division name | Department of Neuropsychiatry |
| Address | 2630 Sugitani, Toyama |
| TEL | 076-434-7323 |
| yhiguchi@med.u-toyama.ac.jp | |
| Public contact | |
| Name of contact person | Yuko Higuchi |
| Organization | University of Toyama |
| Division name | Department of Neuropsychiatry |
| Address | 2630 Sugitani, Toyama |
| TEL | 076-434-7323 |
| Homepage URL | |
| yhiguchi@med.u-toyama.ac.jp | |
| Sponsor | |
| Institute | Department of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Department of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | N/A |
| Name of secondary funder(s) | N/A |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 富山大学附属病院/Toyama University Hospital |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000028446 |